Join
Live feed
·
INSIDERFilingvia Quantisnow
Recro Pharma Inc. logo

SEC Form 4: Ashton William bought $10,111 worth of shares (22,222 units at $0.46), increasing direct ownership by 9% to 263,622 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track REPH (Recro Pharma Inc.) and more on Quantisnow.